On a molecular level, FOP is caused by a gain-of-function mutation in the activin A receptor type I (ACVR1, also known as activin-like kinase 2, ALK2), a type I receptor in the bone morphogenetic protein (BMP) pathway (Shore et al, 2006). The gene discussed is ACVR1; the disease is fibrodysplasia ossificans progressiva.